International Society of Nephrology: Industry Supported Content

ISN GREEN-K Webinar: Advances in green technologies

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

Contains 1 Component(s) Recorded On: 04/30/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Contains 1 Component(s) Recorded On: 04/22/2025
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

Contains 1 Component(s) Recorded On: 03/12/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Contains 1 Component(s) Recorded On: 03/07/2025
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Importance of prevention and delaying kidney failure in Green Nephrology

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
Industry Webinar: APOL1-Mediated Kidney Disease (AMKD): Beneath the Surface of CKD in People of African Ancestry

Contains 1 Component(s)
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN Webinar: How GLP1 receptor agonist evolved from weight management drugs to kidney protective therapy?

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information

Industry Supported Content

ISN GREEN-K Webinar: Advances in green technologies

ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

ISN GREEN-K Webinar: Importance of prevention and delaying kidney failure in Green Nephrology

Industry Webinar: APOL1-Mediated Kidney Disease (AMKD): Beneath the Surface of CKD in People of African Ancestry

ISN Webinar: How GLP1 receptor agonist evolved from weight management drugs to kidney protective therapy?

Global Operations Center

Americas Operations Center

Industry Supported Content

ISN GREEN-K Webinar: Advances in green technologies

ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

ISN GREEN-K Webinar: Importance of prevention and delaying kidney failure in Green Nephrology

Industry Webinar: APOL1-Mediated Kidney Disease (AMKD): Beneath the Surface of CKD in People of African Ancestry

ISN Webinar: How GLP1 receptor agonist evolved from weight management drugs to kidney protective therapy?

Global Operations Center

Americas Operations Center

Follow Us